The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SNF-CLIMEDIN: A prospective randomized trial of digital intervention in patients with advanced NSCLC—A HeCOG study.
 
Paris A. Kosmidis
Travel, Accommodations, Expenses - AstraZeneca/Greece; Pfizer Hellas
 
Thanos Kosmidis
No Relationships to Disclose
 
Kyriaki Papadopoulou
No Relationships to Disclose
 
Nikolaos Korfiatis
No Relationships to Disclose
 
Athanassios Vozikis
Speakers' Bureau - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb; MSD; Novo Nordisk; Roche; Takeda
 
Sofia Lampaki
No Relationships to Disclose
 
Amanda Psyrri
Honoraria - Astrazeneca; Bayer; BMS; Genesis Pharmaceuticals; GlaxoSmithKline; Merck Serono; merus; MSD Oncology; Pfizer; Roche; seagen
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; eTheRNA immunotherapies; GlaxoSmithKline; Merus NV; MSD Oncology; Pfizer; Seagen
Research Funding - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Demo Pharmaceutical; Kura Oncology; Pfizer; Pharmathen; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; Ipsen; MSD Oncology; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; AstraZeneca
 
Elena Fountzilas
Stock and Other Ownership Interests - Deciphera; Genprex
Honoraria - Amgen; AstraZeneca; AstraZeneca (I); Pfizer; Roche; Roche/Genentech
Consulting or Advisory Role - Amgen; Pfizer (I); Roche (I); Sanofi (I)
Travel, Accommodations, Expenses - AstraZeneca; Genesis Pharmaceuticals; Pfizer
 
Athina Christopoulou
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD; SERVIER
Consulting or Advisory Role - AstraZeneca; MSD; SERVIER
 
Epaminondas Samantas
Honoraria - Amgen; AstraZeneca; MSD
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD
 
Anastasios Vagionas
Honoraria - Amgen; BMS GmbH & Co. KG; MSD; Roche
Consulting or Advisory Role - Lilly; Merck Serono; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Roche
 
Giannis Socrates Mountzios
Honoraria - Amgen; AstraZeneca; BMS GmbH & Co. KG; Boehringer Ingelheim; MSD; Novartis; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca/Greece; BMS GmbH & Co. KG; MSD; Novartis; Roche; Takeda
Speakers' Bureau - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; BMS GmbH & Co. KG; Demo Pharmaceutical; Ipsen; MSD; Novartis; Roche
 
Georgios Gkoumas
No Relationships to Disclose
 
Nikolaos Tsoukalas
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck; Roche
Research Funding - Gilead Sciences; Leo Pharma; Merck
Travel, Accommodations, Expenses - Ipsen; Leo Pharma; Teva
 
Ilias Athanasiadis
Employment - MITERA; SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Leadership - MITERA; SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Stock and Other Ownership Interests - SCIENTIFIC EDUCATIONAL ONCOLOGY SOCIETY THINKING DIFFERENTLY BY ACTING ONCOLOGY
Honoraria - Amgen; Astellas Pharma; AstraZeneca; BMSi; Genesis Pharma; Gilead Sciences Hellas; GlaxoSmithKline; INTEGRIS PHARMA; Ipsen; JANSSEN CILAG; LEO Pharma; Lilly; MSD Oncology; Novartis; Pfizer Hellas; PHARMABIDE; Pierre Fabre Hellas; QUALITIS EPE; Roche; SERVIER; SPECIFAR
Consulting or Advisory Role - AMGEN; AstraZeneca; Genesis Pharmaceuticals; GILEAD SCIENCES HELLAS; GLAXOSMITHKLINE; INTEGRIS PHARMA; JANSSEN CILAG; LILLY; MERCH SHARP & DOHME; MSD Oncology; NOVARTIS; Pfizer; PHARMABIDE; Pierre Fabre Hellas; QUALITIS; ROCHE; SERVIER; SPECIFAR
Travel, Accommodations, Expenses - AstraZeneca; MSD Oncology; Pfizer Hellas
(OPTIONAL) Uncompensated Relationships - HECOG
 
Dimitris Bafaloukos
No Relationships to Disclose
 
Chris G. Panopoulos
Honoraria - AstraZeneca
 
Margarita Ioanna Koufaki
Employment - ICON Clinical Research
 
George Fountzilas
Stock and Other Ownership Interests - Daiichi Sankyo; Deciphera (I); FORMYCON; Genprex; Genprex (I); Rafael Holdings
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Amgen (I); Novartis
Speakers' Bureau - Amgen (I); AstraZeneca (I); GlaxoSmithKline (I); Pfizer (I)
Travel, Accommodations, Expenses - AstraZeneca (I); Genesis Pharmaceuticals (I); Pfizer (I)
 
Helena Linardou
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb/Pfizer; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Pfizer; GlaxoSmithKline; MSD Oncology; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer Hellas